2024 Highlights
- In 2024, 14% of cases were due to P. vivax; there were 13% in 2023
- Most cases reported travel to countries in West Africa, with the top destinations of Liberia, Ethiopia, and Kenya
- Of the 65 cases with known country of birth, only four cases were born in the United States
In 2024, 84 cases (1.6 per 100,000 population) were reported, a decrease from the record 90 cases in 2023. Sixty-four (76%) cases were identified with P. falciparum, twelve (14%) with P. vivax, three (4%) with P. malariae, and three (4%) with P. ovale. In two cases (2%), the testing performed was unable to identify a species. The median age of cases was 38 years (range, 5 to 79). Of the 78 cases with known race, 66 (85%) were Black, eight (10%) were white, and five (6%) identified as other race. Eighty-two (98%) cases were Minnesota residents at the time of their illness, 69 (84%) of whom resided in the seven-county metropolitan area. Of the 65 cases with known country of birth, eight (12%) were born in the United States. Exposure and travel information was available for all cases, and while 80 (95%) cases likely acquired malaria in Africa, four cases reported travel to Central and South America. Twenty countries were considered possible exposure locations for malaria infections, the majority of which were in Africa including Liberia (21), Ethiopia (18), Kenya (10), Nigeria (8), and Sierra Leone (5) as well as several other countries in sub-Saharan Africa.